Hunk is required for HER2/neu-induced mammary tumorigenesis

作者: Elizabeth S. Yeh , Thomas W. Yang , Jason J. Jung , Heather P. Gardner , Robert D. Cardiff

DOI: 10.1172/JCI42928

关键词:

摘要: Understanding the molecular pathways that contribute to aggressive behavior of human cancers is a critical research priority. The SNF1/AMPK-related protein kinase Hunk overexpressed in subsets breast, ovarian, and colon cancers. Analysis Hunk(–/–) mice revealed this required for metastasis c-myc–induced mammary tumors but not primary tumor formation. Similar c-myc, amplification proto-oncogene HER2/neu occurs 10%–30% breast associated with behavior. By crossing transgenic mouse models HER2/neu-induced tumorigenesis, we report formation induced by HER2/neu. Knockdown reconstitution experiments cancer cell lines demonstrated maintenance tumorigenic phenotype HER2/neu-transformed cells. This requirement dependent resulted from ability suppress apoptosis association downregulation suppressor p27(kip1). Additionally, find rapidly upregulated following activation vivo vitro. These findings provide what believe first evidence role tumorigenesis survival identify as an essential effector oncogenic pathway.

参考文章(98)
Jiang Li, Xin-Ke Yang, Meng-Liang Ge, Wen-Liang Wang, Yun-De Hou, Xin-Xin Yu, Jie Zhang, Overexpression of p27KIP1 induced cell cycle arrest in G1 phase and subsequent apoptosis in HCC-9204 cell line World Journal of Gastroenterology. ,vol. 6, pp. 513- 521 ,(2000) , 10.3748/WJG.V6.I4.513
H Esumi, M Kaminishi, G Kusakai, T Ogura, A Suzuki, Strong association of ARK5 with tumor invasion and metastasis. Journal of Experimental & Clinical Cancer Research. ,vol. 23, pp. 263- 268 ,(2004)
Matthew L. Fero, Erin Randel, Kay E. Gurley, James M. Roberts, Christopher J. Kemp, The murine gene p27Kip1 is haplo-insufficient for tumour suppression Nature. ,vol. 396, pp. 177- 180 ,(1998) , 10.1038/24179
Vito J. Spataro, Heather Litman, Giuseppe Viale, Fausto Maffini, Michele Masullo, Rastko Golouh, Francisco J. Martinez-Tello, Piergioranni Grigolato, Keith B. Shilkin, Barry A. Gusterson, Monica Castiglione-Gertsch, Karen Price, Jurii Lindtner, Hernan Cortés-Funes, Edda Simoncini, Michael J. Byrne, John Collins, Richard D. Gelber, Alan S. Coates, Aron Goldhirsch, Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V. Cancer. ,vol. 97, pp. 1591- 1600 ,(2003) , 10.1002/CNCR.11224
Abdissa Negassa, Ronald A. DePinho, Richard G. Pestell, Anne T. Reutens, Mark Stahl, Robert G. Russell, Chris Albanese, Maofu Fu, Kongming Wu, William J. Muller, Michael White, Han Woong Lee, Dolores Di Vizio, Mark D'Amico, The Role of Ink4a/Arf in ErbB2 Mammary Gland Tumorigenesis Cancer Research. ,vol. 63, pp. 3395- 3402 ,(2003)
Steven Seelig, Carlos L. Arteaga, Walter King, F. Michael Yakes, Wichai Chinratanalab, Christoph A. Ritter, Herceptin-induced Inhibition of Phosphatidylinositol-3 Kinase and Akt Is Required for Antibody-mediated Effects on p27, Cyclin D1, and Antitumor Action Cancer Research. ,vol. 62, pp. 4132- 4141 ,(2002)
Dagmar Busse, Carlos L. Arteaga, F. Michael Yakes, Anne E. G. Lenferink, W. Michael Flanagan, ErbB2/neu Kinase Modulates Cellular p27Kip1 and Cyclin D1 through Multiple Signaling Pathways Cancer Research. ,vol. 61, pp. 6583- 6591 ,(2001)